MedPath

Role of ulinastatin in pancreatitis

Phase 4
Conditions
Health Condition 1: K859- Acute pancreatitis, unspecified
Registration Number
CTRI/2019/07/020313
Lead Sponsor
Maulana Azad Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients aged 18 - 80 years with severe acute pancreatitis presenting to Lok Nayak Hospital

Exclusion Criteria

1. Mild pancreatitis

2. Pregnancy

3. Lactation

4. Allergy to ulinastatin

5. Chronic pancreatitis

6. Traumatic pancreatitis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Mortality <br/ ><br>Timepoint: 1 week, 2 weeks, 1 month and 3 months
Secondary Outcome Measures
NameTimeMethod
ocal and systemic complications <br/ ><br>Duration of stay in hospital <br/ ><br>Need for surgical interventionTimepoint: 1 week, 2 weeks, 1 month and 3 months
© Copyright 2025. All Rights Reserved by MedPath